Markels John bought PCVX
July 16, 2026 · Form 4 insider transaction
Markels John bought 23,029 shares of Vaxcyte, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
23,029
Price
$0.00
Total value
N/A
InsiderMarkels John
RoleDirector
CompanyVaxcyte, Inc. (PCVX)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 16, 2026
Filing dateJuly 16, 2026
Shares owned after23,029
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Option shall vest over 36 months, 1/3 of which will vest on July 16, 2027 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.